Last reviewed · How we verify
NCT05822219
Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases
NA trial testing COVID-19 vaccine and booster training, and importance in Rheumatic Diseases in 60 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2026
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 15 March 2024 |
| Primary completion | 31 March 2026 |
| Estimated completion | 30 March 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- COVID-19 vaccine and booster training, and importance
Conditions studied
- Rheumatic Diseases — all drugs for Rheumatic Diseases →
- COVID-19 Vaccine — all drugs for COVID-19 Vaccine →
- COVID-19 — all drugs for COVID-19 →
- SLE — all drugs for SLE →
Sponsor
Northwestern University
Who can join
Adults 18 to 85, any sex, with Rheumatic Diseases or COVID-19 Vaccine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions.
Sirek G, Erickson D, Muhammad LN, Losina E, et al · · 2024 · cited 3× · PMID 39181556 · DOI 10.1136/bmjopen-2024-087918 -
Interventions to Improve COVID-19 Vaccine Hesitancy.
Ezeh N, Boadi T, Danila MI, Ramsey-Goldman R, et al · · 2025 · cited 1× · PMID 39550107 · DOI 10.1016/j.rdc.2024.09.007 -
A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole.
Sirek G, Ulysse S, Jacques Toussaint M, Nosamiefan C, et al · · 2024 · cited 1× · PMID 38458871 · DOI 10.1016/j.vaccine.2024.02.079
Verify or expand the search:
- PubMed search for NCT05822219
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatic Diseases
Currently open trials in the same condition.
- NCT07490041 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refr · EARLY_PHASE1 · recruiting
- NCT07350395 — Exploring and Measuring the Impact of Steroids in Children and Young People · recruiting
- NCT07278609 — The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions · recruiting
- NCT07148414 — A Study of SPY072 in Rheumatic Disease · Phase 2 · recruiting
- NCT06400628 — Effectiveness of Chronic Self-management Education on Behavioral and Clinical Outcomes · NA · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05822219 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05822219.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing